By Bhanvi Satija LONDON, July 20 (Reuters) – Novartis investors will look beyond Tuesday's quarterly results for indications about three major drug trial readouts due in the second half of the year
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Volkswagen workers threaten strikes unless carmaker reverses labour deal cancellations
FRANKFURT, Oct 23 (Reuters) - Labour leaders on Friday threatened strikes at Volkswagen from January…
Order Further Strengthens Magellanic Cloud’s Presence in the Railway, Transportation and Critical Infrastructure Surveillance Segment…
FIFA president Infantino feels 'great' after getting AFC support
VIDEO SHOWS: FIFA PRESIDENT GIANNI INFANTINO AT VENUE IN TOKYO WHERE ASIAN FOOTBALL CONFEDERATION EXTRAORDINARY…
